StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) shareholders

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-3.04%)

Close on Nov 17, 2026Market cap $1.60MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
2.6%
1M of 20M shares
Institutional holders
23
3 new, 4 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $1.81M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Michael C. Skaff
Joint filing with SP Manager LLC (19.90%), V-Co Investors 3 LLC (9.70%) and 1 more
2,783,10219.90%13D (active)Jun 30, 2026
SP Manager LLC
Joint filing with Michael C. Skaff (19.90%), V-Co Investors 2 LLC (12.30%) and 1 more
1,342,49819.90%13D (active)Jun 9, 2025
Dawei Luo572,0168.52%13G (passive)Jul 8, 2025
Michael Skaff
Joint filing with V-CO Investors LLC (9.90%), SP Manager LLC (9.90%)
514,4989.90%13G (passive)Dec 17, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of VVOSValueChange% of portfolio
Geode Capital Management, LLC85,0010.42%$38.63K−10,5420.00%
IHT Wealth Management, LLC76,7360.38%$34.88K+35,6750.00%
Vanguard Capital Management LLC60,6290.30%$27.59K−212,7000.00%
Commonwealth Equity Services, LLC42,5000.21%$19.32K–0.00%
UBS Group AG39,1540.19%$17.82K+28,1080.00%
B. Riley Wealth Advisors, Inc.38,0660.19%$18.77K–0.00%
Centurion Wealth Management LLC35,6840.18%$16.22K–0.00%
BlackRock, Inc.27,8170.14%$12.64K–0.00%
State Street Corp24,9220.12%$11.33K–0.00%
Sequoia Financial Advisors, LLC24,0000.12%$10.91K–0.00%
Vanguard Fiduciary Trust Co23,4320.12%$10.66K−7,4000.00%
Northern Trust Corp20,7750.10%$9.44K+8,2640.00%
Acorn Wealth Advisors, LLC14,7760.07%$6.72K–0.00%
Susquehanna International Group, Llp10,0750.05%$4.58KNew0.00%
Tower Research Capital LLC (TRC)5,2110.03%$2.37K−2,1770.00%
Osaic Holdings, Inc.1,1430.01%$516–0.00%
Signaturefd, LLC5470.00%$249–0.00%
Integrated Wealth Concepts LLC3200.00%$144New0.00%
Ronald Blue Trust, Inc.1600.00%$73–0.00%
Kozak & Associates, Inc.490.00%$24–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026231M2.6%3 / 34 / 40M1M
Q1 2026242M9.1%8 / 32 / 22M0M
Q4 2025191M3.3%1 / 63 / 50M0M
Q3 2025231M3.4%7 / 45 / 30M0M
Q2 2025190M2.0%4 / 52 / 50M0M
Q1 2025210M1.7%6 / 81 / 40M0M
Q4 2024200M2.3%2 / 42 / 50M0M
Q3 2024230M1.2%6 / 53 / 20M0M
Q2 2024190M0.9%5 / 32 / 20M0M
Q1 2024160M0.7%3 / 41 / 30M0M
Q4 2023170M1.3%17 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held VVOS in Q2 2026, 44% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of VVOSValue% of fundAs of
Fidelity Extended Market Index Fund60,7690.30%$42.54K0.00%May 31, 2026
Vanguard Extended Market Index Fund60,6290.30%$27.56K0.00%Jun 30, 2026
Fidelity Total Market Index Fund12,0720.06%$8.45K0.00%May 31, 2026
Fidelity Series Total Market Index Fund8,3500.04%$5.85K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-4,300-0.02%-$1.95K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ronald Kirk HuntsmanChief Executive Officer, Director158,9710.79%Sep 18, 2026
Bradford K. AmmanPrincipal Accounting Officer250,0801.24%Aug 26, 2026
Anja B. KrammerDirector––Oct 27, 2026
Mark F. LindsayDirector––Oct 26, 2026
Ralph Elias GreenDirector––Oct 26, 2026
Gregg C. JohnsonDirector3,9970.02%Sep 18, 2026
Leonard J. SokolowDirector––Sep 18, 2026
Investors 4 LLC V-Co10% owner––Jul 15, 2026
Michael C. Skaff10% owner1,342,4986.67%Jul 15, 2026
Investors 3 LLC V-Co10% owner2,398,40211.92%Apr 10, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bradford K. Amman
Principal Accounting Officer
Jul 31, 2026Award+250,000$0.41$102.50K250,080
Ronald Kirk Huntsman
Chief Executive Officer, Director
Jun 30, 2026Other+85,910$0.58$49.83K85,910
Investors 3 LLC V-Co
10% owner
Mar 31, 2026Buy+1,044,777$1.34$1.40M1,044,777
Investors 3 LLC V-Co
10% owner
Mar 31, 2026Buy+308,848$1.34$413.86K1,353,625
Ronald Kirk Huntsman
Chief Executive Officer, Director
Jun 20, 2023Buy+14,000$0.53$7.42K86,521
Ronald Kirk Huntsman
Chief Executive Officer, Director
Jun 16, 2023Buy+10,000$0.54$5.40K67,521
Ronald Kirk Huntsman
Chief Executive Officer, Director
Jun 16, 2023Buy+5,000$0.53$2.65K72,521
Ronald Kirk Huntsman
Chief Executive Officer, Director
Jun 15, 2023Buy+21$0.50$1157,521
Ronald Kirk Huntsman
Chief Executive Officer, Director
Jun 14, 2023Buy+10,000$0.49$4.90K57,500
Ronald Kirk Huntsman
Chief Executive Officer, Director, 10% owner
Dec 23, 2022Buy+20,000$0.50$10.00K47,500
Ronald Kirk Huntsman
Chief Executive Officer, Director, 10% owner
Jun 1, 2022Buy+4,000$1.83$7.32K27,500
Ronald Kirk Huntsman
Chief Executive Officer, Director, 10% owner
May 31, 2022Buy+8,000$2.03$16.24K23,500
Ronald Kirk Huntsman
Chief Executive Officer, Director
Sep 21, 2021Buy+5,000$4.31$21.55K15,500
Ronald Kirk Huntsman
Chief Executive Officer, Director
Aug 17, 2021Buy+5,000$3.00$15.00K10,500
Bradford K. Amman
Chief Financial Officer
May 25, 2021Buy+1,000$5.29$5.29K2,000
Ronald Kirk Huntsman
Chief Executive Officer, Director
May 25, 2021Buy+4,000$5.38$21.52K5,500
Bradford K. Amman
Chief Financial Officer
Dec 24, 2020Buy+1,000$7.38$7.38K1,000
Ronald Kirk Huntsman
Chief Executive Officer, Director, 10% owner
Dec 23, 2020Buy+1,000$7.27$7.27K1,500
Ronald Kirk Huntsman
Chief Executive Officer, Director, 10% owner
Dec 11, 2020Buy+500$8.50$4.25K500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
21.90%
3M shares short
Days to cover
1.0
At 12M shares a day
Change since last report
+30.1%
From 2M shares
Short volume, 20 days
22.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Vivos Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 11,976,326 shares on Sep 1, 2026 over the last 90 days.

See a number that looks wrong?